CXCL8 and acute promyelocytic leukemia: Nevertheless, no previous study has investigated and compared the IL-8 plasma levels in the plasma of DS and non-DS patients with APL during the treatment with ATRA to determine whether this cytokine has the potential to predict the development of the APL-DS.